19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace.

SCAMHC serves all individuals regardless of inability to pay. Discounts for essential services are offered based on family size and income. For more information, contact (334) 222-2523 or our 24/7 Helpline at 1-877-530-0002.

 

 


powered by centersite dot net
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
U.S. Teachers Often Faced Harassment, Violence During Pandemic: PollOmicron Wave Had 5 Times as Many Small Kids Hospitalized Compared to DeltaSuicide Rate Is Spiking Upwards in Preadolescent ChildrenAHA News: Bystander CPR on Kids Differs by Race and EthnicityNew Malaria Treatment Gets First Approval for Use in ChildrenMental Health of America's Children Only Getting WorseTalking to Your Kids About the War in UkraineOdds for Mental Illness Rise in Kids After ConcussionPfizer Begins Trial of COVID Drug Paxlovid in Kids 6 to 17Pfizer Vaccine Much Less Potent in Kids Aged 5-11COVID Has Robbed 5.2 Million Children Worldwide of Parent, CaregiverNew Drug May Help Curb COVID-Linked Inflammatory Disorder in KidsPoll Finds Most Parents Would Use CBD to Treat a Child — Is That Wise?Does Your Child Have Asthma? Look for the SignsResearch May Help Focus Treatment for Kids With Cystic FibrosisSleepless Children Often Become Sleepless Adults: StudyA Healthy Mouth Could Be a Lifesaver for Kids With Heart ConditionsSeasonal Flu Shots Give Kids Broader Protection Against New StrainsU.S. Kids Still Dying From Toppling TVs, FurnitureKids With COVID-Linked MIS-C Have Long-Term SymptomsAHA News: Amid a National Mental Health Crisis For Kids, Here's How Parents Can HelpParents: What You Need to Know About Kids & COVID-19Getting Active Soon After Concussion May Aid Kids' RecoveryPfizer Asks FDA to Approve Its Vaccine for Youngest KidsThe 'Oreo Test' and Other Ways to Help Kids' Oral HealthPfizer Will Ask FDA to Approve Its COVID Vaccine for Kids Under 5Getting Your School-Age Child Into a Healthy Sleep RoutineGenes Could Help Drive Febrile Convulsions in KidsMore Than 1 Million U.S. Kids Diagnosed With COVID in Single WeekPandemic Especially Tough on Kids With ADHDBrain Implant for Adults With Epilepsy Can Help Kids, TooCOVID Can Affect Brains of Hospitalized KidsMany Kids Aren't Wearing Helmets While Sledding, Poll FindsMany Marijuana Vendors Aim Advertising at Kids: StudyHeart Function Rebounds for Kids With COVID-Linked MIS-CWhich Kids Are Most Vulnerable to Severe COVID-19?At-Home COVID Tests Accurate for Ki​ds: StudyCDC Study Shows Power of Flu Vaccine for KidsCOVID Hospitalizations Rising in Kids Too Young for VaccineNearly 600,000 U.S. Kids Had COVID Last WeekWhite House to Give Schools 10 Million Free COVID Tests Every MonthKids' Behavior Worsened With Remote Learning: StudyLater School Start Times Boost Parents' Health, TooUrban Air Pollution Drives Millions of Cases of Asthma in KidsCDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between ShotsA Better Way to Correct Severe Scoliosis in Kids?Getting Your Child Their Vaccine?  Some Tips on Easing Needle FearsU.S. Hospitals Seeing Record Numbers of Young COVID PatientsSevere Illness in Children Brings Hardship for FamiliesReal-World Data Confirms Pfizer Vaccine Safe for Kids Ages 5-11
Questions and AnswersVideosLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting

Pfizer Vaccine Much Less Potent in Kids Aged 5-11


HealthDay News
Updated: Mar 1st 2022

new article illustration

TUESDAY, March 1, 2022 (HealthDay News) -- Fresh data shows that Pfizer's COVID vaccine is far less powerful at preventing infection among children ages 5 to 11 than teens, a finding that could leave some parents of younger children worried.

The vaccine -- the only one authorized for that age group in the United States -- does prevent severe illness in young children, according to data collected during the Omicron surge. But it offers almost no protection against coronavirus infection, even within a month after full immunization, researchers said.

Why? One reason may be that children receive one-third the dose given to older children and adults, researchers and federal officials who have reviewed the data told The New York Times. The disappointing findings follow recent trial results that showed the vaccine performed poorly in children aged 2 to 4, who received an even smaller dose.

“It’s disappointing, but not entirely surprising, given this is a vaccine developed in response to an earlier variant,” said study leader Eli Rosenberg, deputy director for science at the New York State Department of Health. “It looks very distressing to see this rapid decline, but it’s again all against Omicron.”

The findings were published in the preprint server medRxiv, and have not yet been peer-reviewed.

Despite the lackluster results, Rosenberg and other public health experts said they recommend the shot for children, because the vaccine continues to guard against severe disease in this group.

“We need to make sure we emphasize the doughnut and not the hole,” Dr. Kathryn Edwards, a pediatric vaccine expert at Vanderbilt University, told the Times.

In the latest study, Rosenberg and his colleagues analyzed data from 852,384 fully vaccinated children aged 12 to 17 and 365,502 fully vaccinated children aged 5 to 11 between the middle of December and the end of January.

The vaccine’s effectiveness against hospitalization declined to 73 percent from 85 percent in the older children. In the younger children, effectiveness dropped to 48 percent from 100 percent. But because very few children were hospitalized, these estimates have wide margins of error, the Times said.

The vaccine's performance against infection was even worse: It dropped to 51 percent from 66 percent in older children, while it plummeted to 12 percent from 68 percent in younger children.

The numbers change dramatically between ages 11 and 12. During the week ending Jan. 30, the vaccine’s effectiveness against infection was 67 percent in 12-year-olds, but just 11 percent in 11-year-old children, the study found.

“The difference between the two age groups is striking,” Florian Krammer, an immunologist at the Icahn School of Medicine at Mount Sinai, told the Times.

The difference may be due to dosage: While 12-year-old children got 30 micrograms of the vaccine -- the same dose given to adults -- children who were 11 and younger received only 10 micrograms, he noted.

“This is super interesting because it would almost suggest that it’s the dose that makes the difference,” he added. “The question is how to fix that.”

Just days ago, the U.S. Centers for Disease Control and Prevention released new recommendations that would allow the majority of Americans to stop wearing masks, including in schools.

The new data also raises important questions about the Biden administration’s strategy for vaccinating younger children. Only about one in four children aged 5 to 11 has received two doses of the vaccine. And the U.S. Food and Drug Administration had already postponed an expert panel meeting to weigh two doses of the vaccine for children under 5 after Pfizer submitted more data suggesting two doses were not strongly protective against the Omicron variant.

Importantly, Pfizer, Moderna and Johnson and Johnson are all testing Omicron-specific versions of their vaccines.

Many parents want to vaccinate their children to prevent them from spreading the virus to vulnerable relatives, to keep them in school or to avoid the possibility of long COVID. Experts acknowledged that the latest data does little to ease those concerns.

Still, the vaccines “provide more protection than we think,” Jessica Andriesen, a vaccine data expert at the Fred Hutchinson Cancer Research Center in Seattle, told the Times. “They may also make it so that your kid who brings home COVID isn’t shedding virus as much as they would be if they weren’t vaccinated, and they also may have it for a shorter amount of time."

More information

Visit the U.S. Centers for Disease Control and Prevention for more on COVID vaccines and kids.


SOURCE: The New York Times